Pursuant to section 35(1)(c) of the Medicines Act 1981, the Minister of Health hereby revokes consent to the distribution in New Zealand of the following medicine:
Schedule
Product: Luveris
Active Ingredient: Lutropin alfa, rch 22.5mcg
Dosage Form: Solution for injection
New Zealand Sponsor: Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Manufacturer: Merck Serono SpA, Aubonne, Switzerland
Dated this 22nd day of August 2014.
STEWART JESSAMINE, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).